INVO Bioscience (NASDAQ:INVO) Stock Price Down 4.5% – Here’s What Happened

INVO Bioscience, Inc. ( NASDAQ:INVO – Get Free Report )’s share price traded down 4.5% during mid-day trading on Monday .

The stock traded as low as $0.81 and last traded at $0.81.



19,996 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 1,587,563 shares. The stock had previously closed at $0.85.

INVO Bioscience Stock Down 4.5 % The company’s fifty day simple moving average is $0.79 and its 200-day simple moving average is $0.

83. Institutional Investors Weigh In On INVO Bioscience An institutional investor recently bought a new position in INVO Bioscience stock. CWC Advisors LLC.

bought a new position in INVO Bioscience, Inc. ( NASDAQ:INVO – Free Report ) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 100,477 shares of the company’s stock, valued at approximately $71,000.

CWC Advisors LLC. owned about 2.64% of INVO Bioscience as of its most recent filing with the Securities and Exchange Commission.

Institutional investors and hedge funds own 12.02% of the company’s stock. INVO Bioscience Company Profile INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide.

It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida. See Also Five stocks we like better than INVO Bioscience What Investors Must Know About Over-the-Counter (OTC) Stocks Is Monolithic Power Systems a Screaming Buy After Near 40% Drop? The How And Why of Investing in Oil Stocks Applied Materials Market Capitulates: Now is the Time to Buy What is a SEC Filing? 3 Ultra-High Dividend Yield Stocks for the New Year Receive News & Ratings for INVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Bioscience and related companies with MarketBeat.

com's FREE daily email newsletter ..